Sale!

COQ8A Gene Spinocerebellar Ataxia Type 9 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COQ8A gene spinocerebellar ataxia type 9 (SCAR9) autosomal recessive genetic test is a specialized diagnostic tool used to identify mutations in the COQ8A gene, which are linked to the development of SCAR9. Spinocerebellar ataxia type 9 is a rare genetic disorder characterized by progressive difficulties with coordination and movement, stemming from degeneration in specific areas of the brain, particularly the cerebellum. The autosomal recessive nature of the condition means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

The test involves analyzing the individual’s DNA, extracted from a blood sample, to look for specific genetic alterations in the COQ8A gene that are known to cause SCAR9. This genetic testing is crucial for early diagnosis, which can help in managing symptoms, planning for future healthcare needs, and providing information for family planning decisions.

In the United Arab Emirates, this genetic test is available at DNA Labs UAE, a leading provider of genetic testing services. The cost of the COQ8A gene spinocerebellar ataxia type 9 autosomal recessive genetic test at DNA Labs UAE is 4400 AED. This test is a significant resource for families and individuals at risk of SCAR9, offering them a chance to understand their genetic status and make informed decisions about their health and well-being.

Description

COQ8A Gene Spinocerebellar Ataxia Type 9 Autosomal Recessive Genetic Test

Test Name: COQ8A Gene Spinocerebellar Ataxia Type 9 Autosomal Recessive Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COQ8A Gene Spinocerebellar Ataxia Type 9, Autosomal Recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COQ8A Gene Spinocerebellar Ataxia Type 9, Autosomal Recessive.

Test Details: The COQ8A gene is associated with Spinocerebellar Ataxia Type 9 (SCA9), an autosomal recessive form of ataxia. Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of multiple genes simultaneously. In the case of SCA9, NGS genetic testing can be used to identify mutations or variations in the COQ8A gene that may be responsible for the development of the condition. By analyzing the DNA sequence of the COQ8A gene, NGS testing can identify specific genetic changes, such as deletions, insertions, or single nucleotide variants (SNVs), that may be associated with SCA9. This information can help diagnose individuals with SCA9 and provide valuable information for genetic counseling and family planning. It is important to note that while NGS testing can identify genetic changes associated with SCA9, it does not provide a cure for the condition. Treatment for SCA9 is typically focused on managing symptoms and providing supportive care to improve quality of life. If you suspect that you or someone you know may have SCA9, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance on the appropriate genetic testing options and help interpret the results.

Test Name	COQ8A Gene Spinocerebellar ataxia type 9 autosomal rececssive Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for COQ8A Gene Spinocerebellar ataxia type 9, autosomal rececssive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with COQ8A Gene Spinocerebellar ataxia type 9, autosomal rececssive
Test Details	The COQ8A gene is associated with Spinocerebellar Ataxia Type 9 (SCA9), an autosomal recessive form of ataxia. Next-generation sequencing (NGS) genetic testing is a method used to analyze the DNA sequence of multiple genes simultaneously. In the case of SCA9, NGS genetic testing can be used to identify mutations or variations in the COQ8A gene that may be responsible for the development of the condition. By analyzing the DNA sequence of the COQ8A gene, NGS testing can identify specific genetic changes, such as deletions, insertions, or single nucleotide variants (SNVs), that may be associated with SCA9. This information can help diagnose individuals with SCA9 and provide valuable information for genetic counseling and family planning. It is important to note that while NGS testing can identify genetic changes associated with SCA9, it does not provide a cure for the condition. Treatment for SCA9 is typically focused on managing symptoms and providing supportive care to improve quality of life. If you suspect that you or someone you know may have SCA9, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance on the appropriate genetic testing options and help interpret the results.